Skip directly to content


Lyrica® works as a neurotransmitters blocker, regulates the hyper-excited neurons back to normal threshold1-2. Lyrica® has been approved in the USA and EU3-4 .


  1. Kavoussi, Richard. "Pregabalin: From Molecule to Medicine." European Neuropsychopharmacology 16.2 (2006): S128-133. Web.
  2. Lyrica® (pregabalin) Prescribing Information. Pfizer Corporation Hong Kong Limited: version January 2018.
  3. US. Food and Drug Administration. Approved drug products: Lyrica Pregabalin. Available at: Accessed on 19 June 2019
  4. European Medicine Agency. Lyrica Pregabalin authorization details. Available at: Accessed on 18 June 2019.
[PP-CPF-HKG-0060] SEP 2019